Agreement expands access to the Cerapedics portfolio of peptide-powered drug-device products for spinal fusion procedures WESTMINSTER, Colo., April 24, 2026 /PRNewswire/ — Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair,…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
